South America Gastroparesis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

No. of Pages: 101    |    Report Code: TIPRE00024818    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Gastroparesis Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Gastroparesis Market – By Type

1.3.2        SAM Gastroparesis Market – By Drug Class Type

1.3.3        SAM Gastroparesis Market – By Distribution Channel

1.3.4        SAM Gastroparesis Market – By Country

2.           SAM Gastroparesis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Gastroparesis Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Expert Opinion

5.           SAM Gastroparesis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Diabetes Mellitus Rising at Swift Pace

5.1.2        Geriatric Population Growing

5.2         Market Restraints

5.2.1        Gastroparesis Drugs Showing Various Side Effects

5.3         Market Opportunities

5.3.1        Significant Financial Assistance for Research Work

5.4         Future Trends

5.4.1        Gastric Electrical Stimulation Therapy Research Taken Seriously

5.5         Impact Analysis

6.           Gastroparesis Market – SAM Analysis

6.1         SAM Gastroparesis Market Revenue Forecast and Analysis

7.           SAM Gastroparesis Market Analysis – By Type

7.1         Overview

7.2         SAM Gastroparesis Market Revenue Share, by Type (2019 and 2027)

7.3         Idiopathic

7.3.1        Overview

7.3.2        Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Diabetic

7.4.1        Overview

7.4.2        Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Post-Surgical

7.5.1        Overview

7.5.2        Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.           SAM Gastroparesis Market Analysis – By Drug Class Type

8.1         Overview

8.2         SAM Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

8.3         Prokinetic Agents

8.3.1        Overview

8.3.2        Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Botulinum Toxin Injection

8.4.1        Overview

8.4.2        Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Antiemetic Agents

8.5.1        Overview

8.5.2        Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.           SAM Gastroparesis Market Analysis – By Distribution Channel

9.1         Overview

9.2         SAM Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.        SAM Gastroparesis Market – Country Analysis

10.1      Overview

10.1.1     SAM: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.1.2     Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.1       Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.2       Brazil Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.3       Brazil Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.4       Brazil Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.3     Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       Argentina Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.3       Argentina Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.4       Argentina Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.3.5       Rest of SAM: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)

10.1.3.6       Rest of SAM: Gastroparesis Market- Revenue and Forecasts to 2027 (USD Million)

10.1.3.7       Rest of SAM Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.8       Rest of SAM Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.9       Rest of SAM Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Global Gastroparesis Market

11.1      SAM: Impact Assessment of COVID-19 Pandemic

12.        Gastroparesis Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Gastroparesis Market, 2018-2020

12.3      Inorganic Growth Strategies

12.3.1     Overview

12.4      Organic Growth Strategies

12.4.1     Overview

13.        Company Profiles

13.1      Allergan Plc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Bausch Health Companies Inc. (Salix Pharmaceuticals)

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Johnson and Johnson Services, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Pfizer Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Ipca Laboratories Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             Brazil Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             Brazil Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4.             Argentina Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Argentina Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Argentina Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7.             Rest of SAM Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Rest of SAM Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Rest of SAM Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10.          Recent Inorganic Growth Strategies in the Gastroparesis market

Table 11.          Glossary of Terms, Gastroparesis Market

LIST OF FIGURES

Figure 1.           SAM Gastroparesis Market Segmentation

Figure 2.           SAM Gastroparesis Market Segmentation, By Country

Figure 3.           SAM Gastroparesis Market Overview

Figure 4.           Idiopathic Segment Held Largest Share of SAM Gastroparesis Market

Figure 5.           Brazil to Show Remarkable Growth During Forecast Period

Figure 6.           SAM PEST Analysis

Figure 7.           SAM Gastroparesis Market Impact Analysis of Drivers and Restraints

Figure 8.           SAM Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.           SAM Gastroparesis Market Revenue Share, by Type (2019 and 2027)

Figure 10.        SAM Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        SAM Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        SAM Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        SAM Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        SAM Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

Figure 15.        SAM Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        SAM Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        SAM Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        SAM Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 19.        SAM Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        SAM Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        SAM Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        SAM: Gastroparesis Market, by Key Country – Revenue (2019) (US$ Million)

Figure 23.        SAM: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 24.        Brazil: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Argentina: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Rest of SAM: Gastroparesis Market- Revenue And Forecasts To 2027 (USD Million)

Figure 27.        Impact Of COVID-19 Pandemic in SAM Market

Figure 28.        Growth Strategies in the Gastroparesis Market, 2018-2020

The List of Companies - South America Gastroparesis Market

  1. Allergan Plc
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Ipca Laboratories Ltd.
  4. Johnson and Johnson Services, Inc.
  5. Pfizer Inc.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD